We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+19.18%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$14.1B
AUM Growth
+$3.8B
Cap. Flow
+$2.09B
Cap. Flow %
14.81%
Top 10 Hldgs %
19.63%
Holding
2,124
New
675
Increased
443
Reduced
410
Closed
576

Top Sells

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$131M
2
MSFT icon
Microsoft
MSFT
+$129M
3
V icon
Visa
V
+$119M
4
BKNG icon
Booking.com
BKNG
+$86M
5
HUM icon
Humana
HUM
+$82.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Technology 15.37%
3 Consumer Discretionary 10.44%
4 Industrials 8.59%
5 Financials 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMTL icon
1076
Comtech Telecommunications
CMTL
$51.8M
$125K ﹤0.01%
5,397
-19,012
-78% -$471K
EC icon
1077
Ecopetrol
EC
$34.5B
$125K ﹤0.01%
5,852
-219,045
-97% -$4.29M
QTWO icon
1078
Q2 Holdings
QTWO
$3.92B
$125K ﹤0.01%
1,800
+812
+82% +$50.7K
HSII
1079
DELISTED
Heidrick & Struggles
HSII
$124K ﹤0.01%
3,224
+3,065
+1,928% +$111K
HP icon
1080
Helmerich & Payne
HP
$3.71B
$122K ﹤0.01%
2,200
-24,056
-92% -$1.31M
LDOS icon
1081
Leidos
LDOS
$17.3B
$122K ﹤0.01%
1,909
-54,019
-97% -$3.26M
VFC icon
1082
VF Corp
VFC
$5.89B
$122K ﹤0.01%
+1,487
New +$116K
AIV
1083
Aimco
AIV
$383M
$121K ﹤0.01%
18,016
-68,447
-79% -$441K
MPT
1084
Medical Properties Trust
MPT
$2.81B
$120K ﹤0.01%
+6,499
New +$116K
MMS icon
1085
Maximus
MMS
$3.1B
$119K ﹤0.01%
+1,671
New +$117K
THR
1086
DELISTED
Thermon Group Holdings
THR
$119K ﹤0.01%
+4,828
New +$115K
CNOB icon
1087
Center Bancorp
CNOB
$1.78B
$118K ﹤0.01%
5,963
+494
+9% +$10.1K
SENS icon
1088
Senseonics Holdings Inc
SENS
$366M
$118K ﹤0.01%
+2,413
New +$128K
INDP icon
1089
Indaptus Therapeutics
INDP
$157M
$117K ﹤0.01%
+7
New +$123K
BAH icon
1090
Booz Allen Hamilton
BAH
$9.15B
$116K ﹤0.01%
+2,000
New +$104K
WDAY icon
1091
Workday
WDAY
$44.4B
$115K ﹤0.01%
+598
New +$109K
EGAN icon
1092
eGain
EGAN
$201M
$114K ﹤0.01%
+10,935
New +$104K
RGA icon
1093
Reinsurance Group of America
RGA
$16.1B
$114K ﹤0.01%
800
-8,727
-92% -$1.26M
AER icon
1094
AerCap
AER
$23.8B
$112K ﹤0.01%
+2,400
New +$108K
DESP
1095
DELISTED
Despegar.com
DESP
$112K ﹤0.01%
+7,462
New +$118K
HMHC
1096
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$112K ﹤0.01%
15,463
-2,116
-12% -$19K
HRTX icon
1097
Heron Therapeutics
HRTX
$92.9M
$111K ﹤0.01%
4,522
-6,815
-60% -$178K
GTHX
1098
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$110K ﹤0.01%
6,620
-82,289
-93% -$1.56M
AXGN icon
1099
Axogen
AXGN
$2.5B
$109K ﹤0.01%
5,160
-3,205
-38% -$58.5K
CBZ icon
1100
CBIZ
CBZ
$2.96B
$107K ﹤0.01%
5,267

Similar funds

Marshall Wace North America's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace North America held 2,124 positions worth $14.1B, up 37% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America deployed $2.09B of net new capital in Q1 2019, opening 675 new positions and adding to 443 existing holdings. Its largest new stake was bluebird bio: 36,744 shares worth $74.9M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Comcast, an estimated $131M trimmed.

  • Marshall Wace North America's largest Q1 2019 buy was bluebird bio: 36,744 shares worth $74.9M.
  • Marshall Wace North America added most to Fidelity National Information Services in Q1 2019, an estimated $188M increase.
  • Marshall Wace North America's biggest Q1 2019 reduction was Comcast, cutting an estimated $131M.
  • Marshall Wace North America fully exited Cboe Global Markets in Q1 2019, selling an estimated $67.7M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $14.1B portfolio in Q1 2019.
  • Marshall Wace North America opened 675 new positions and closed 576 in Q1 2019.
  • Marshall Wace North America's portfolio value rose 37% quarter-over-quarter to $14.1B.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.